Kilobaser sells a benchtop DNA and RNA synthesizer for in-house production of custom oligos. The One-XT extended edition adds modified DNA and RNA synthesis, using a closed cartridge and microfluidic chip system. The company positions the device for labs that need rapid, on-demand synthesis and same-day troubleshooting.
Kilobaser primarily focuses on the biotechnology industry, specifically in the development of microfluidic technology for DNA and RNA synthesis.
Direct sales of synthesizers and consumables, subscription services for software and support.
Kilobaser's main competitors in the DNA and RNA synthesis market include:
DNA Script: Specializes in enzymatic DNA synthesis technology with its SYNTAX System, a benchtop DNA printer for on-demand production. This technology is advantageous for rapid DNA synthesis, particularly in genomics and personalized medicine.
Twist Bioscience: Offers a semiconductor-based DNA synthesis platform known for high-throughput capabilities, which is beneficial for drug discovery and large-scale applications. Their extensive product portfolio positions them strongly in the market.
Evonetix: Developing a desktop DNA synthesis platform that synthesizes gene-length DNA with high quality. Their focus on localized synthesis may appeal to smaller labs needing efficient solutions.
Molecular Assemblies: Utilizes Fully Enzymatic Synthesis (FES) technology for producing DNA strands, emphasizing efficiency and sustainability in their processes.
Ansa Biotechnologies: Focuses on DNA synthesis technology using enzymes, with significant funding backing their innovations.
Nuclera Nucleics: Develops a desktop bioprinter for producing genes and proteins, which allows for flexible and localized production.
Helixworks Technologies: Specializes in programmable DNA data storage, offering unique solutions for data encoding in molecular structures.
Iridia: Focuses on advanced molecular technology for product authenticity and traceability, applicable across various industries.
Kilobaser differentiates itself with its specific focus on microfluidic chip and cartridge-based synthesizers, enabling quick and affordable custom DNA and RNA production, which may not be the primary focus of its competitors.